近红外激光激活的PLGA-PDA核壳纳米杂化物用于正畸白斑病变预防的协同光热抗菌与持续离子释放
本研究开发了封装Ag/CuO纳米颗粒的PLGA-PDA核壳纳米杂化物,经0.5 W 980 nm近红外照射后聚多巴胺产热并持续释放抗菌药物16天,对变形链球菌有强杀菌活性,可有效预防正畸白斑病变,体内实验显示抗炎与促再生且生物相容性良好。
要点
- 0.5 W 980 nm近红外激活可实现光热与Ag+/Cu2+持续释放的双重抗菌。
- 纳米杂化物对变形链球菌浮游菌及牙菌斑生物膜均有抑制作用。
- 体内实验显示IL-6表达近乎缺失且VEGF/TGF-β上调,生物相容性良好。
核心结论
- Ag/CuONPs@PLGA/PDA微球经0.5 W近红外触发可控制释放药物,有效抑制变形链球菌浮游菌及牙菌斑生物膜形成,从而预防正畸白斑病变。
- 该微球可减轻创面炎症、加速组织再生并具有良好生物相容性。
研究设计与样本
- 通过双乳液与自聚合方法将Ag/CuO纳米颗粒封装于PLGA/PDA纳米球,制备核壳颗粒。
- 对核壳颗粒进行组成、粒径分布、zeta电位、形貌、光热性能、释放动力学及细胞相容性表征。
- 在近红外激光照射下评估对变形链球菌的杀菌效果及预防正畸白斑病变的潜力。
主要发现
- 合成的Ag/CuONPs@PLGA/PDA纳米颗粒呈均匀纳米级分布且zeta电位稳定。
- 在0.5 W 980 nm近红外照射下,光响应聚多巴胺涂层快速将光转化为热能,实现持续16天的抗菌药物释放。
- 该纳米颗粒对变形链球菌具有强杀菌活性,有效预防正畸白斑病变。
- 体内分析显示IL-6表达近乎缺失,VEGF/TGF-β极化上调,增强抗炎反应并促进血管生成与组织再生。
- 主要器官组织病理学检查未见明显炎症,确认系统生物相容性。
关键数值与推荐
- 近红外照射参数为0.5 W、980 nm。
- 抗菌药物持续释放时间为16天。
临床怎么用
- 该核壳纳米杂化物可配制成正畸粘接剂或隐形矫治器表面的抗菌涂层。
- 通过偶尔的近红外激活,实现局部光热「爆发」与持续Ag⁺/Cu²⁺释放,按需杀灭变形链球菌并保护周围组织。
- 将双模式防御整合入常规矫治器,可能在不影响粘接强度或生物相容性的前提下显著降低白斑病变发生率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop near-infrared (NIR) laser-activated PLGA-PDA core-shell nanohybrids encapsulating Ag/CuO nanoparticles for simultaneous photothermal antibacterial therapy and sustained Ag+/Cu2+ release, and to evaluate their bactericidal efficacy against Streptococcus mutans and preventive potential in orthodontic white spot lesions. METHODS: Ag/CuO nanoparticles were encapsulated in PLGA/PDA nanospheres via a double-emulsion and self-polymerization approach. The resulting core-shell particles were fully characterized for composition, size distribution, zeta potential, morphology, photothermal performance, release kinetics, and cytocompatibility. Finally, we assessed their bactericidal efficacy under NIR laser irradiation against Streptococcus mutans and evaluated their potential to prevent orthodontic white-spot lesions. RESULTS: Synthesized Ag/CuONPs@PLGA/PDA nanoparticles exhibit uniform nanoscale distribution and stable zeta potential. Upon 0.5 W 980-nm NIR irradiation, the photoresponsive polydopamine coating rapidly converts light to thermal energy, enabling sustained antibacterial drug release for 16 days. This confers potent bactericidal activity against Streptococcus mutans, effectively preventing orthodontic white spot lesions. Crucially, in vivo analysis demonstrates near-absent IL-6 expression with polarized VEGF/TGF-β upregulation, enhancing anti-inflammatory responses while promoting angiogenesis and tissue regeneration. Histopathological examination of major organs reveals no significant inflammation, confirming systemic biocompatibility. CONCLUSION: Triggered by brief near-infrared irradiation (0.5 W), Ag/CuONPs@PLGA/PDA sustained-release microspheres enable controlled drug release that effectively suppresses both Streptococcus mutans planktonic cells and dental plaque biofilm formation, thereby preventing orthodontic white spot lesions. Furthermore, these microspheres significantly attenuate wound-site inflammation, accelerate tissue regeneration, and demonstrate excellent biocompatibility. CLINICAL SIGNIFICANCE: The Ag/CuONPs@PLGA/PDA core-shell nanohybrids reported here can be readily formulated into antimicrobial coatings for orthodontic adhesives or clear aligner surfaces. Upon occasional NIR activation, they deliver a localized photothermal "burst" together with sustained Ag⁺/Cu²⁺ release, achieving potent, on-demand eradication of Streptococcus mutans while preserving surrounding tissues. By integrating this dual-mode defense into routine appliances, clinicians may substantially reduce the incidence of white spot lesions without compromising bonding strength or biocompatibility, ultimately improving treatment outcomes and patient satisfaction.
引用
- Feng Z, Liu Y, Sun S, et al. Near-infrared laser-activated PLGA-PDA core-shell nanohybrids for synergistic photothermal antibacterial therapy and sustained ion release in orthodontic white spot lesions prevention. J Dent. 2025. PMID: 40889546. doi:10.1016/j.jdent.2025.106078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。